Composition
- Active ingredients
- ERYTHROMYCIN 333MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN 500MG · Tablet, delayed releaseANDA062999-001 · Discontinued
- ERYTHROMYCIN 333MG · Tablet, delayed releaseThis page
- ERYTHROMYCIN 333MG · Tablet, delayed releaseANDA063086-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA063028.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- E-Base
- Active substance
- erythromycin
- Route
- Oral
- Dosage form
- Tablet, delayed release
- Applicant
- Barr
- Status
- Discontinued
- FDA approval
- 15 May 1990
- Application
- ANDA063028-001